These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12962689)

  • 1. Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions.
    Radziuk J; Pye S
    Best Pract Res Clin Endocrinol Metab; 2003 Sep; 17(3):323-42. PubMed ID: 12962689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?
    Radziuk J; Pye S
    Diabetologia; 2006 Jul; 49(7):1619-28. PubMed ID: 16752180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution.
    Radziuk J; Pye S
    Diabetologia; 2002 Aug; 45(8):1053-84. PubMed ID: 12189437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion.
    Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1990 Oct; 33(10):603-10. PubMed ID: 2257997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
    Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
    J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.
    Paquot N; Schneiter P; Jéquier E; Gaillard R; Lefèbvre PJ; Scheen A; Tappy L
    Diabetologia; 1996 May; 39(5):580-6. PubMed ID: 8739918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous glucose production in type 2 diabetes: basal and postprandial. Role of diurnal rhythms.
    Radziuk J; Pye S
    J Investig Med; 2004 Sep; 52(6):379-88. PubMed ID: 15612451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of post-absorptive glucose kinetics in non-insulin-dependent diabetic patients: methodological aspects.
    Rigalleau V; Beylot M; Laville M; Guillot C; Deleris G; Aubertin J; Gin H
    Eur J Clin Invest; 1996 Mar; 26(3):231-6. PubMed ID: 8904352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
    Boden G; Chen X; Stein TP
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method.
    Toffolo G; Basu R; Dalla Man C; Rizza R; Cobelli C
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E800-6. PubMed ID: 16720627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus.
    Radziuk J; Pye S
    Diabetologia; 2001 Aug; 44(8):983-91. PubMed ID: 11484075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus.
    Habito RC; Barnett M; Yamamoto A; Cameron-Smith D; O'Dea K; Zimmet P; Collier GR
    Acta Diabetol; 1995 Oct; 32(3):187-92. PubMed ID: 8590789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal glucose metabolism in type 2 diabetes. A critical review.
    Hother-Nielsen O; Beck-Nielsen H
    Diabete Metab; 1991 May; 17(1 Pt 2):136-45. PubMed ID: 1936467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus.
    Clore JN; Allred J; White D; Li J; Stillman J
    Metabolism; 2002 Nov; 51(11):1471-7. PubMed ID: 12404200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats.
    Hoenig M; Thomaseth K; Brandao J; Waldron M; Ferguson DC
    Domest Anim Endocrinol; 2006 Nov; 31(4):373-89. PubMed ID: 16434162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin decreases insulin secretion in patients with type 2 diabetes mellitus.
    Pereira Arias AM; Romijn JA; Corssmit EP; Ackermans MT; Nijpels G; Endert E; Sauerwein HP
    Metabolism; 2000 Jul; 49(7):839-44. PubMed ID: 10909992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose fluxes during OGTT in adolescents assessed by a stable isotope triple tracer method.
    Toffolo G; Dalla Man C; Cobelli C; Sunehag AL
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):31-45. PubMed ID: 18404971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT.
    Hovorka R; Shojaee-Moradie F; Carroll PV; Chassin LJ; Gowrie IJ; Jackson NC; Tudor RS; Umpleby AM; Jones RH
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E992-1007. PubMed ID: 11934663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.